Home › Funds › Sanders Capital, LLC › ABT

Sanders Capital, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Sanders Capital, LLC reported holding 1,004,725 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$99.3M, representing 0.10% of its reported portfolio and ranking #39 among its reported holdings. Sanders Capital, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)1.00M sh
Reported value held$99.30M
Portfolio Weight0.10%
First reportedQ4 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Sanders Capital, LLC's ABT position evolved

Sanders Capital, LLC first disclosed a stake in ABT in Q4 2023 at 1,193,078 shares (US$131.3M). The position peaked in Q2 2025 at 1,187,695 shares, worth US$161.5M. Across 12 filings, Sanders Capital, LLC increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 1,004,725 shares valued at US$99.3M — a reduction of -45,680 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2023 1.19M $131.32M New
Q1 2024 1.19M $135.59M Hold
Q2 2024 1.20M $124.51M Hold
Q3 2024 1.20M $136.26M Hold
Q4 2024 1.19M $135.03M Hold
Q1 2025 1.19M $157.39M Reduce
Q2 2025 1.19M $161.54M Hold
Q3 2025 1.19M $158.89M Hold
Q4 2025 1.15M $144.28M Reduce
Q1 2026 1.12M $115.11M Reduce
Q2 2026 1.05M $95.31M Reduce
Q3 2026 1.00M $99.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Sanders Capital, LLC held ABT?

Sanders Capital, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Sanders Capital, LLC's current position in ABT?

As of Q3 2026, Sanders Capital, LLC holds 1.00M shares of ABT (ABBOTT LABORATORIES), valued at $99.30M, representing 0.10% of its reported portfolio and ranking #39.

Has Sanders Capital, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Sanders Capital, LLC reduced its position in ABT. The position peaked in Q2 2025 at 1.19M shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.